Skip to content

Application of rapid immunohistochemical technique in intraoperative diagnosis of prostate biopsy

Application of rapid immunohistochemical technique in intraoperative diagnosis of prostate biopsy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300073701
Enrollment
Unknown
Registered
2023-07-19
Start date
2022-10-18
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PROSTATE CANCER

Interventions

Gold Standard:The pathological diagnosis results of prostate biopsy serve as the "gold standard" for preoperative diagnosis of prostate cancer
Index test:intraoperative frozen rapid immunohistochemical staining

Sponsors

Beijing Hospital
Lead Sponsor

Eligibility

Sex/Gender
Male
Age
18 Years to 85 Years

Inclusion criteria

Inclusion criteria: (1) Age = 85 years, ECOG score = 1, no obvious surgical contraindications; (2) Patients suspected of prostate cancer due to PSA abnormalities or digital rectal examination abnormalities, or MRI suspected prostate cancer .

Exclusion criteria

Exclusion criteria: (1) Patients with severe cardiopulmonary disease and other related diseases, unable to tolerate surgery; (2) Patients who have received endocrine therapy or pelvic radiotherapy before surgery; (3) Patients who have undergone prostate surgery; (4) Patients who are considered unsuitable for enrollment by the investigator.

Design outcomes

Primary

MeasureTime frame
Accuracy of intraoperative frozen rapid immunohistochemical staining in the diagnosis of prostate cancer.;

Secondary

MeasureTime frame
Risk factors affecting the accuracy of intraoperative freezing, intraoperative frozen pathology versus postoperative pathology in terms of Gleason score compliance and diagnostic accuracy.;

Countries

CHINA

Contacts

Public ContactLONGTENG LIU

Beijing Hospital

305354696@qq.com+86 188 1086 3229

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026